Perceptive Advisors »

Surrozen shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.7M 229k 29.13

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Ascendis Pharma A/s Sponsored Adr
Roivant Sciences SHS (ROIV)
Centessa Pharmaceuticals Sponsored Ads
Rhythm Pharmaceuticals (RYTM)
Spyre Therapeutics Com New (SYRE)
Nuvalent Inc-a (NUVL)
Edgewise Therapeutics (EWTX)
Protagonist Therapeutics (PTGX)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Amylyx Pharmaceuticals (AMLX)
Immatics SHS (IMTX)
Relay Therapeutics (RLAY)

View all positions for Perceptive Advisors

Top funds holding Surrozen

TCG Crossover Management
Boxer Capital Management
Millennium Management
VR Adviser
Stempoint Capital
Braidwell
5AM Venture Management
Kalehua Capital Management
Vestal Point Capital
Vivo Capital
Perceptive Advisors
Woodline Partners
Balyasny Asset Management
Ikarian Capital
Longwood Capital Partners

View all funds holding Surrozen